Cancer Prevention and Screening
Clinicians
Resources
Billing
Patient Self-Pay
Color’s self-pay price is $249. Patients can pay in the provider’s office or at home via credit card. Payment is required before the test can be processed.
Insurance Billing (Hereditary Cancer In-Clinic Only)
Color makes pricing transparent for both you and your patients from the start. Our smart, online tools are designed to enable you and your patients to access the lowest estimated payment option available. We review your patient’s insurance information and assess their payment options using your patient’s deductible, co-insurance, and health plan details.
When you submit an online order through the Color Provider Platform, our online tool can quickly determine if your patient is eligible for insurance billing.
If your patient’s out-of-pocket (OOP) is estimated to be less than Color’s self-pay price and they meet medical criteria, Color will submit the claim to the insurance plan.
For the following health plans, complete and include the following forms with your Color order: Billing and Insurance Information (Hereditary Cancer Only)
Forms
Peer-Reviewed Publications
LEAP: Using machine learning to support variant classification in a clinical setting
Human Mutation (2020)
Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores
Genome Medicine (2019)
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Nature Communications (2020)
Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines
Journal of Molecular Diagnostics (2019)
Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Journal of the National Cancer Institute (2019)
A scalable, aggregated genotypic–phenotypic database for human disease variation
Database (2019)
Research Posters
Expecting the Unexpected: Hereditary Cancer and Cardiovascular Findings in an Employer-Sponsored Genetic Testing Program
ACMG 2020
An integrated end-to-end platform for engaged population-scale genomics
ASHG 2019
Delivering high-quality, scalable genetic counseling in international settings: case studies from Trinidad and Tobago and the United Arab Emirates
ASHG 2019
Detecting Copy Number Variation on Low Coverage Whole Genome Sequencing
ASHG 2019
Common variant genetic background modifies risk of breast cancer among carriers of pathogenic germline risk variants
ASHG 2019
Participant screening behaviors and information sharing after genetic testing
ISPOR 2019
Impact of non-clinical genetic trait insights on clinical engagement in participants after clinical genetic testing
ASHG 2019
Phenotypic and Genotypic Spectrum Identified in a Cohort of Germline TP53 Carriers
ACMG 2019
Recent Blog Posts
See all blog posts
Cancer Prevention and Screening
Screening is just the beginning. That’s why we’re expanding support from diagnosis management through remission.
Cancer Prevention and Screening
How 30,000 People Took More Control of Their Health: A Milestone in Accessible Personalized Medicine
